QA: Mirati Therapeutics Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001576263_2020_Mirati_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001576263, Mirati Therapeutics Inc.

  xvar xval
0 AssetsCurrent 424,407,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,776,000
3 remainder_Assets 6,017,000
4 LiabilitiesCurrent 48,906,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 999,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 42,573,000
9 ResearchAndDevelopmentExpense 182,866,000
10 remainder_Expenses 0
11 remainder_Revenues 3,335,000
12 remainder_NetIncome 8,848,000
13 remainder_ComprehensiveNetIncome 410,000
  yvar yval
0 Assets 432,200,000
1 Liabilities 49,905,000
2 Expenses 225,439,000
3 Revenues 3,335,000
4 StockholdersEquity 382,295,000
5 NetIncome -213,256,000
6 ComprehensiveNetIncome -213,051,000
7 BaseVar 360,068,500
8 EconomicCapitalRatio 1.84

Edgar->Model Mapping

Feature Distribution

Change over Time